The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 1, 2009, Pages 190-196

  Prudente, Sabrina ^a,b   Scarpelli, Daniela ^c   Chandalia, Manisha ^d,e   Zhang, Yuan Yuan ^f,g   Morini, Eleonora ^a,h   Del Guerra, Silvia ⁱ   Perticone, Francesco ^c   Li, Rong ^d,e   Powers, Christine ^f   Andreozzi, Francesco ^c   Marchetti, Piero ⁱ   Dallapiccola, Bruno ^a,h   Abate, Nicola ^d,e   Doria, Alessandro ^f,g   Sesti, Giorgio ^c   Trischitta, Vincenzo ^a,b,h  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b CSS Scientific Institute   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f JOSLIN DIABETES CENTER   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; DNA; GLUCOSE; TRIB3 Q84R PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CAUCASIAN; CELL ISOLATION; CELL SECRETION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN RELEASE; INSULIN SENSITIVITY; JUVENILE DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET; PANCREAS ISLET CELL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 58149389465     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1365     Document Type: Article

References (33)

1. Hansen L, Pedersen O 2005 Genetics of type 2 diabetes mellitus: status and perspectives. Diabetes Obes Metab 7:122-135
2. Frayling TM 2007 Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 8:657-662
3. Bloomgarden ZT 2004 Type 2 diabetes in the young: the evolving epidemic. Diabetes Care 27:998-1010
4. Hillier TA, Pedula KL 2001 Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care 24:1522-1527
5. Hillier TA, Pedula KL 2003 Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diabetes Care 26:2999-3005
6. Weijnen CF, Rich SS, Meigs JB, Krolewski AS, Warram JH 2002 Risk of diabetes in siblings of index cases with type 2 diabetes: implications for genetic studies. Diabet Med 19:41-50
7. Mitchell BD, Kammerer CM, Reinhart LJ, Stern MP 1994 NIDDM in Mexican-American families. Heterogeneity by age of onset. Diabetes Care 17:567-573
8. Frayling TM, Wiltshire S, Hitman GA, Walker M, Levy JC, Sampson M, Groves CJ, Menzel S, McCarthy MI, Hattersley AT 2003 Young-onset type 2 diabetes families are the major contributors to genetic loci in the Diabetes UK Warren 2 genome scan and identify putative novel loci on chromosomes 8q21, 21q22, and 22q11. Diabetes 52:1857-1863
9. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR 1992 Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 17:925-929
10. Du K, Herzig S, Kulkarni RN, Montminy M 2003 TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 6:1574-1577
11. Prudente S, Hribal ML, Flex E, Turchi F, Morini E, De Cosmo S, Bacci S, Tassi V, Cardellini M, Lauro R, Sesti G, Dallapiccola B, Trischitta V 2005 The functional Q84R polymorphism of mammalian Tribbles homolog TRB3 is associated with insulin resistance and related cardiovascular risk in Caucasians from Italy. Diabetes 54:2807-2811
12. Andreozzi F, Formoso G, Prudente S, Hribal ML, Pandolfi A, Bellacchio E, Di Silvestre S, Trischitta V, Consoli A, Sesti G 2008 TRIB3 R84 variant is associated with impaired insulin mediated nitric oxide production in human endothelial cells. Arterioscler Thromb Vasc Biol 28:1355-1360
13. Okamoto H, Latres E, Liu R, Thabet K, Murphy A, Valenzeula D, Yancopoulos GD, Stitt TN, Glass DJ, Sleeman MW 2007 Genetic deletion of Trb3, the mammalian Drosophila tribbles homolog, displays normal hepatic insulin signaling and glucose homeostasis. Diabetes 56:1350-1356
14. De Cosmo S, Prudente S, Andreozzi F, Morini E, Rauseo A, Scarpelli D, Zhang YY, Xu R, Perticone F, Dallapiccola B, Sesti G, Doria A, Trischitta V 2007 Glutamine to arginine substitution at amino acid 84 of mammalian tribbles homolog TRIB3 and CKD in whites with type 2 diabetes. Am J Kidney Dis 50:688-689
15. Wee Liew C, Bochenski J, Hu J, Krowleski AS, Kulkarni RN Effects of TRB3 on β-cell insulin exocytosis. Proc 68th Scientific Sessions of the American Diabetes Association, San Francisco, CA, 2008, 186-OR (Abstract)
16. Zeggini E, Scott LJ, Saxena R, Voight BF, for the Diabetes Genetics Replication and Meta-analysis DIAGRAM Consortium 2008 Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40:638-645
17. American Diabetes Associations 2004 Screening for diabetes. Diabetes Care 27(Suppl 1):S11-S14
18. Abdul-Ghani MA, Williams K, De Fronzo RA, Stern M 2007 What is the best predictor of future type 2 diabetes? Diabetes Care 30:1544-1548
19. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 9:1462-1470
20. Marchetti P, Lupi R, Federici M, Marselli L, Masini M, Boggi U, Del Guerra S, Patane G, Piro S, Anello M, Bergamini E, Purrello F, Lauro R, Mosca F, Sesti G, Del Prato S 2002 Insulin secretory function is impaired in isolated human islets carrying the Gly(972)->Arg IRS-1 polymorphism. Diabetes 51:1419-1424
21. Tian C, Plenge RM, Ransom M, Lee A, Villoslada P, Selmi C, Klareskog L, Pulver AE, Qi L, Gregersen PK, Seldin MF 2008 Analysis and application of European genetic substructure using 300KSNP information. PLoS Genet 1:e4
22. Price AL, Butler J, Patterson N, Capelli C, Pascali VL, Scarnicci F, Ruiz-Linares A, Groop L, Saetta AA, Korkolopoulou P, Seligsohn U, Waliszewska A, Schirmer C, Ardlie K, Ramos A, Nemesh J, Arbeitman L, Goldstein DB, Reich D, Hirschhorn JN 2008 Discerning the ancestry of European Americans in genetic association studies. PLoS Genet 1:e236
23. Lyssenko V, Almgren P, Anevski D, Perfekt R, Lahti K, Nissén M, Isomaa B, Forsen B, Homström N, Saloranta C, Taskinen MR, Groop L, Tuomi T; Botnia Study Group 2005 Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 54:166-174
24. Stumvoll M, Fritsche A, Volk A, Stefan N, Madaus A, Maerker E, Teigeler A, Koch M, Machicao F, Haring H 2001 The Gly972Arg polymorphism in the insulin receptor substrate-1 gene contributes to the variation in insulin secretion in normal glucose-tolerant humans. Diabetes 50:882-885
25. Clausen JO, Hansen T, Bjorbaek C, Echwald SM, Urhammer SA, Rasmussen S, Andersen CB, Hansen L, Almind K, Pedersen O 1995 Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 346:397-402
26. Marini MA, Frontoni S, Mineo D, Bracaglia D, Cardellini M, De Nicolais P, Baroni A, D'Alfonso R, Perna M, Lauro D, Federici M, Gambardella S, Lauro R, Sesti G 2003 The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients. J Clin Endocrinol Metab 88:3368-3371
27. Almind K, Inoue G, Pedersen O, Kahn CR 1996 A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. J Clin Invest 11:2569-2575
28. Zeggini E, Parkinson J, Halford S, Owen KR, Frayling TM, Walker M, Hitman GA, Levy JC, Sampson MJ, Feskens EJ, Hattersley AT, McCarthy MI 2004 Association studies of insulin receptor substrate 1 gene (IRS1) variants in type 2 diabetes samples enriched for family history and early age of onset. Diabetes 53:3319-3322
29. Florez JC, Sjögren M, Burtt N, Orho-Melander M, Schayer S, Sun M, Almgren P, Lindblad U, Tuomi T, Gaudet D, Hudson TJ, Daly MJ, Ardlie KG, Hirschhorn JN, Altshuler D, Groop L 2004 Association testing in 9,000 people fails to confirm the association of the insulin receptor substrate-1 G972R polymorphism with type 2 diabetes. Diabetes 53:3313-3318
30. Baratta R, Rossetti P, Prudente S, Barbetti F, Sudano D, Nigro A, Farina MG, Pellegrini F, Trischitta V, Frittitta L 2008 Role of the ENPP1 K121Q polymorphism on glucose homeostasis. Diabetes 57:3360-3364
31. Bacci S, De Cosmo S, Prudente S, Trischitta V 2007 ENPP1 gene, insulin resistance and related clinical outcomes. Curr Opin Clin Nutr Metab Care 4:403-409
32. McAteer JB, Prudente S, Bacci S, Lyon HN, Hirschhorn JN, Trischitta V, Florez JC; ENPP1 Consortium 2008 The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: evidence from an updated meta-analysis in 42,042 subjects. Diabetes 4:1125-1130
33. Biddinger SB, Kahn CR 2006 From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol 68:123-158